臨床試験支援サービスの世界市場レポート 2025年

臨床試験支援サービス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.5％で336億8,000万米ドルに成長します。予測期間における成長の背景には、個別化医療に対する需要の高まり、慢性疾患の蔓延、研究開発投資の増加、臨床試験に対する規制当局の支援、臨床研究におけるアウトソーシングの拡大、患者中心の臨床試験の重視の高まり、臨床試験の複雑化、新たな治療領域の出現などがあります。この期間に予想される主な動向としては、人工知能と機械学習の統合、ブロックチェーン技術とビッグデータ分析の採用、ウェアラブルデバイスの使用、分散型臨床試験の台頭、電子データ収集と臨床試験管理システムの進歩、遠隔患者モニタリングと仮想臨床試験の拡大などが挙げられます。

個別化医療の台頭は、今後数年間の臨床試験支援サービス市場の成長を牽引すると予想されます。個別化医療は、治療結果を最適化し、治療を強化するために、遺伝的、環境的、ライフスタイル的要因に基づいて個々の患者に合わせた治療を行うものです。個別化医療の採用が増加している背景には、ゲノミクスの進歩、バイオマーカーに基づく診断の利用可能性の拡大、データ分析技術の向上、標的を絞った効果的な治療に対する需要の高まりなどがあります。臨床試験支援サービスは、患者募集の最適化、バイオマーカー主導の試験デザインの実施、法規制遵守の確保など、個別化医療を促進する上で重要な役割を果たしており、これにより個々の遺伝的プロファイルや疾患プロファイルに合わせた治療法の開発が可能になります。例えば、2024年2月、米国の非営利団体である個別化医療連合（PMC）は、米国食品医薬品局（FDA）が2023年に26の新しい個別化治療を承認し、2022年に承認された12から大幅に増加したと報告しました。その結果、個別化医療が重視されるようになり、臨床試験支援サービス市場の拡大に拍車がかかっています。

臨床試験支援サービス市場の主要企業は、リクルートを改善し、リテンションを向上させ、参加者の負担を最小限に抑え、多様な患者集団をより包括的かつポジティブに捉えるため、患者中心の臨床試験の開発にますます注力しています。患者中心の臨床試験とは、患者のニーズ、嗜好、経験を優先するようにデザインされた臨床試験であり、臨床試験プロセス全体を通じて、アクセシビリティ、エンゲージメント、参加者の全体的な満足度を向上させる。例えば、米国を拠点とする患者ファーストのデジタルヘルス企業であるLeal Health社は、2023年3月、画期的な患者中心のプログラムレベル分析プラットフォームを発表しました。このプラットフォームは、製薬会社のオンライン臨床試験ウェブサイトと統合され、製薬会社は、質の高い患者候補を確保し、募集期間を短縮し、シームレスなエンドツーエンドの患者体験を実現するための業務効率を達成するために、患者に焦点を当てた効果的なプログラムを開発・実行することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界臨床試験支援サービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の臨床試験支援サービス市場：成長率分析
• 世界の臨床試験支援サービス市場の実績：規模と成長, 2019-2024
• 世界の臨床試験支援サービス市場の予測：規模と成長, 2024-2029, 2034F
• 世界臨床試験支援サービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臨床試験支援サービス市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験サイト管理
• データ管理
• 患者募集管理
• 管理スタッフ
• 機関審査委員会（IRB）
• その他のサービス
• 世界の臨床試験支援サービス市場フェーズ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前臨床研究
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV
• 世界の臨床試験支援サービス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 中枢神経系（CNS）と精神障害
• 心血管疾患
• 感染症
• 排便障害
• その他の用途
• 世界の臨床試験支援サービス市場臨床試験サイト管理の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サイトの選択
• サイトの開始
• サイト監視
• サイトの閉鎖
• 世界の臨床試験支援サービス市場データ管理の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ収集
• データ検証
• 電子データキャプチャ（EDC）
• 統計分析
• 世界の臨床試験支援サービス市場患者募集管理の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 患者スクリーニング
• 入学戦略
• 保持サービス
• 世界の臨床試験支援サービス市場、管理職の種別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床調査コーディネーター
• プロジェクトマネージャー
• 規制業務スペシャリスト
• 世界の臨床試験支援サービス市場、機関審査委員会（IRB）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 倫理審査
• プロトコルレビュー
• コンプライアンス監視
• 世界の臨床試験支援サービス市場その他のサービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 規制コンサルティング
• 品質保証
• メディカルライティング
• 調査員研修

第7章 地域別・国別分析

• 世界の臨床試験支援サービス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臨床試験支援サービス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臨床試験支援サービス市場：競合情勢
• 臨床試験支援サービス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk A/S
• Iqvia Inc.
• Laboratory Corporation of America Holdings（Labcorp）
• ICON plc
• SGS S.A.
• Eurofins Scientific SE
• WuXi AppTec
• Syneos Health
• Catalent Inc.
• Charles River Laboratories International Inc.
• Medpace Holdings Inc.
• Pharmaron
• MARKEN Ltd.
• Novotech
• ClinChoice Private Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臨床試験支援サービス市場2029：新たな機会を提供する国
• 臨床試験支援サービス市場2029：新たな機会を提供するセグメント
• 臨床試験支援サービス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Clinical trial support services encompass a range of specialized solutions designed to aid in the planning, execution, and management of clinical trials, ensuring regulatory compliance, data integrity, patient recruitment, and overall trial efficiency. These services help streamline the drug development process, minimize operational complexities, and improve the quality and reliability of trial outcomes.

The primary services in the clinical trial support services market include clinical trial site management, data management, patient recruitment management, administrative staff, institutional review board (IRB) services, and others. Clinical trial site management involves coordinating and overseeing all activities at a trial site to ensure regulatory compliance, adherence to protocols, and efficient trial execution. These services span different trial phases, including preclinical studies, Phase I, Phase II, Phase III, and Phase IV, and are applied across various therapeutic areas such as oncology, central nervous system (CNS) and mental disorders, cardiovascular diseases, infectious diseases, blood disorders, and more.

The clinical trial support services market research report is one of a series of new reports from The Business Research Company that provides clinical trial support services market statistics, including clinical trial support services industry global market size, regional shares, competitors with a clinical trial support services market share, detailed clinical trial support services market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial support services industry. This clinical trial support services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial support services market size has grown strongly in recent years. It will grow from $22.62 billion in 2024 to $24.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing outsourcing of clinical trials, rising healthcare expenditures, expansion of the pharmaceutical and biotechnology sectors, regulatory changes and reforms, globalization of clinical trials, the growing prevalence of diseases, increased clinical research funding, and the rising demand for faster drug development.

The clinical trial support services market size is expected to see rapid growth in the next few years. It will grow to $33.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the rising demand for personalized medicine, the increasing prevalence of chronic diseases, higher investments in research and development, regulatory support for clinical trials, the expansion of outsourcing in clinical research, a growing emphasis on patient-centric trials, the increasing complexity of clinical trials, and the emergence of new therapeutic areas. Key trends expected during this period include the integration of artificial intelligence and machine learning, the adoption of blockchain technology and big data analytics, the use of wearable devices, the rise of decentralized clinical trials, advancements in electronic data capture and clinical trial management systems, as well as the expansion of remote patient monitoring and virtual clinical trials.

The rise of personalized medicine is expected to drive the growth of the clinical trial support services market in the coming years. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. The increasing adoption of personalized medicine is fueled by advancements in genomics, the growing availability of biomarker-based diagnostics, improved data analytics technologies, and a rising demand for targeted and effective therapies. Clinical trial support services play a crucial role in facilitating personalized medicine by optimizing patient recruitment, implementing biomarker-driven trial designs, and ensuring regulatory compliance, thereby enabling the development of therapies tailored to individual genetic and disease profiles. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized treatments in 2023, a significant rise from the 12 approved in 2022. As a result, the growing emphasis on personalized medicine is fueling the expansion of the clinical trial support services market.

Leading companies in the clinical trial support services market are increasingly focusing on developing patient-centric trials to improve recruitment, enhance retention, minimize participant burden, and create a more inclusive and positive experience for diverse patient populations. Patient-centric trials are clinical studies designed to prioritize the needs, preferences, and experiences of patients, improving accessibility, engagement, and overall participant satisfaction throughout the trial process. For example, in March 2023, Leal Health, a US-based patient-first digital health company, introduced a groundbreaking patient-centric program-level analytics platform. This platform integrates with pharmaceutical companies' online clinical trial websites, enabling them to develop and execute effective, patient-focused programs to ensure high-quality patient candidates, reduce recruitment timelines, and achieve operational efficiencies for a seamless end-to-end patient experience.

In February 2024, ICON plc, an Ireland-based clinical research organization, acquired Clinical Research Management Inc. for an undisclosed amount. This acquisition strengthens ICON's ability to access the market for government-sponsored research while expanding its expertise in vaccines and infectious disease research. Clinical Research Management Inc. is a US-based contract research organization (CRO) that specializes in providing clinical research and trial services.

Major players in the clinical trial support services market are Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S.A., Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Iqvia Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, SGS S.A., Eurofins Scientific SE, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International Inc., Medpace Holdings Inc., Pharmaron, MARKEN Ltd., Novotech, ClinChoice Private Limited, Medidata Solutions Inc., Premier Research, Quotient Sciences Ltd., Caidya, MMS Holdings Inc., Celerion Inc., Parexel International (MA) Corporation, Alcura Health, Almac Group, Brighter Health Network LLC, and.

North America was the largest region in the clinical trial support services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial support services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the clinical trial support services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial support services market includes revenues earned by entities by providing services such as regulatory affairs and compliance, medical writing and documentation, pharmacovigilance and safety monitoring, biostatistics and data analysis, quality assurance and auditing, and eClinical solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Support Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial support services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial support services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial support services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Clinical Trial Site Management; Data Management; Patient Recruitment Management; Administrative Staff; Institutional Review Board (IRB); Other Services
• 2) By Phases: Preclinical Studies; Phase I; Phase II; Phase III; Phase IV
• 3) By Application: Oncology; Central Nervous System (CNS) And Mental Disorders; Cardiovascular Diseases; Infectious Diseases; Bood Disorders; Other Applications
• Subsegments:
• 1) By Clinical Trial Site Management: Site Selection; Site Initiation; Site Monitoring; Site Close-out
• 2) By Data Management: Data Collection; Data Validation; Electronic Data Capture (EDC); Statistical Analysis
• 3) By Patient Recruitment Management: Patient Screening; Enrollment Strategy; Retention Services
• 4) By Administrative Staff: Clinical Research Coordinators; Project Managers; Regulatory Affairs Specialists
• 5) By Institutional Review Board (IRB): Ethical Review; Protocol Review; Compliance Monitoring
• 6) By Other Services: Regulatory Consulting; Quality Assurance; Medical Writing; Investigator Training
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Support Services Market Characteristics

3. Clinical Trial Support Services Market Trends And Strategies

4. Clinical Trial Support Services Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Clinical Trial Support Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Trial Support Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Trial Support Services Market Growth Rate Analysis
• 5.4. Global Clinical Trial Support Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Trial Support Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Trial Support Services Total Addressable Market (TAM)

6. Clinical Trial Support Services Market Segmentation

• 6.1. Global Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Site Management
• Data Management
• Patient Recruitment Management
• Administrative Staff
• Institutional Review Board (IRB)
• Other Services
• 6.2. Global Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Studies
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.3. Global Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Central Nervous System (CNS) And Mental Disorders
• Cardiovascular Diseases
• Infectious Diseases
• Bood Disorders
• Other Applications
• 6.4. Global Clinical Trial Support Services Market, Sub-Segmentation Of Clinical Trial Site Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site Selection
• Site Initiation
• Site Monitoring
• Site Close-out
• 6.5. Global Clinical Trial Support Services Market, Sub-Segmentation Of Data Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Collection
• Data Validation
• Electronic Data Capture (EDC)
• Statistical Analysis
• 6.6. Global Clinical Trial Support Services Market, Sub-Segmentation Of Patient Recruitment Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Screening
• Enrollment Strategy
• Retention Services
• 6.7. Global Clinical Trial Support Services Market, Sub-Segmentation Of Administrative Staff, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Research Coordinators
• Project Managers
• Regulatory Affairs Specialists
• 6.8. Global Clinical Trial Support Services Market, Sub-Segmentation Of Institutional Review Board (IRB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ethical Review
• Protocol Review
• Compliance Monitoring
• 6.9. Global Clinical Trial Support Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regulatory Consulting
• Quality Assurance
• Medical Writing
• Investigator Training

7. Clinical Trial Support Services Market Regional And Country Analysis

• 7.1. Global Clinical Trial Support Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Trial Support Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Trial Support Services Market

• 8.1. Asia-Pacific Clinical Trial Support Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Trial Support Services Market

• 9.1. China Clinical Trial Support Services Market Overview
• 9.2. China Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Trial Support Services Market

• 10.1. India Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Trial Support Services Market

• 11.1. Japan Clinical Trial Support Services Market Overview
• 11.2. Japan Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Trial Support Services Market

• 12.1. Australia Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Trial Support Services Market

• 13.1. Indonesia Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Trial Support Services Market

• 14.1. South Korea Clinical Trial Support Services Market Overview
• 14.2. South Korea Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Trial Support Services Market

• 15.1. Western Europe Clinical Trial Support Services Market Overview
• 15.2. Western Europe Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Trial Support Services Market

• 16.1. UK Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Trial Support Services Market

• 17.1. Germany Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Trial Support Services Market

• 18.1. France Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Trial Support Services Market

• 19.1. Italy Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Trial Support Services Market

• 20.1. Spain Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Trial Support Services Market

• 21.1. Eastern Europe Clinical Trial Support Services Market Overview
• 21.2. Eastern Europe Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Trial Support Services Market

• 22.1. Russia Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Trial Support Services Market

• 23.1. North America Clinical Trial Support Services Market Overview
• 23.2. North America Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Trial Support Services Market

• 24.1. USA Clinical Trial Support Services Market Overview
• 24.2. USA Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Trial Support Services Market

• 25.1. Canada Clinical Trial Support Services Market Overview
• 25.2. Canada Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Trial Support Services Market

• 26.1. South America Clinical Trial Support Services Market Overview
• 26.2. South America Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Trial Support Services Market

• 27.1. Brazil Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Trial Support Services Market

• 28.1. Middle East Clinical Trial Support Services Market Overview
• 28.2. Middle East Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Trial Support Services Market

• 29.1. Africa Clinical Trial Support Services Market Overview
• 29.2. Africa Clinical Trial Support Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Trial Support Services Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Trial Support Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Trial Support Services Market Competitive Landscape And Company Profiles

• 30.1. Clinical Trial Support Services Market Competitive Landscape
• 30.2. Clinical Trial Support Services Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Trial Support Services Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Iqvia Inc.
• 31.3. Laboratory Corporation of America Holdings (Labcorp)
• 31.4. ICON plc
• 31.5. SGS S.A.
• 31.6. Eurofins Scientific SE
• 31.7. WuXi AppTec
• 31.8. Syneos Health
• 31.9. Catalent Inc.
• 31.10. Charles River Laboratories International Inc.
• 31.11. Medpace Holdings Inc.
• 31.12. Pharmaron
• 31.13. MARKEN Ltd.
• 31.14. Novotech
• 31.15. ClinChoice Private Limited

32. Global Clinical Trial Support Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Support Services Market

34. Recent Developments In The Clinical Trial Support Services Market

35. Clinical Trial Support Services Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Trial Support Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Trial Support Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Trial Support Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer